
Diagnostic and pharmaceutical product manufacturers
Original Title: Driven by the Recovery in Demand for Medical Devices, Abbott Raises Full-Year Profit Forecast Source: Jiemian
According to the RTHK website on the 21st, driven by rising market demand for its novel coronavirus tests and a recovery in demand for medical devices, Abbott has raised its full-year earnings forecast, with adjusted earnings per share from continuing operations expected to be at least $3.55.